IL142292A0 - Ion exchange tumor targeting - Google Patents

Ion exchange tumor targeting

Info

Publication number
IL142292A0
IL142292A0 IL14229299A IL14229299A IL142292A0 IL 142292 A0 IL142292 A0 IL 142292A0 IL 14229299 A IL14229299 A IL 14229299A IL 14229299 A IL14229299 A IL 14229299A IL 142292 A0 IL142292 A0 IL 142292A0
Authority
IL
Israel
Prior art keywords
ion exchange
tumor targeting
tumor
compound
intratumoral
Prior art date
Application number
IL14229299A
Other languages
English (en)
Original Assignee
Map Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Map Ab filed Critical Map Ab
Publication of IL142292A0 publication Critical patent/IL142292A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/06—Macromolecular compounds, carriers being organic macromolecular compounds, i.e. organic oligomeric, polymeric, dendrimeric molecules
    • A61K51/065—Macromolecular compounds, carriers being organic macromolecular compounds, i.e. organic oligomeric, polymeric, dendrimeric molecules conjugates with carriers being macromolecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Optics & Photonics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL14229299A 1998-10-13 1999-10-12 Ion exchange tumor targeting IL142292A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9803482A SE9803482D0 (sv) 1998-10-13 1998-10-13 Ion exchange tumor targeting (IETT)
PCT/SE1999/001837 WO2000021571A1 (en) 1998-10-13 1999-10-12 Ion exchange tumor targeting (iett)

Publications (1)

Publication Number Publication Date
IL142292A0 true IL142292A0 (en) 2002-03-10

Family

ID=20412924

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14229299A IL142292A0 (en) 1998-10-13 1999-10-12 Ion exchange tumor targeting

Country Status (11)

Country Link
US (1) US6569841B1 (xx)
EP (1) EP1137441B1 (xx)
JP (1) JP2002527407A (xx)
AT (1) ATE489971T1 (xx)
AU (1) AU759251B2 (xx)
CA (1) CA2347424C (xx)
DE (1) DE69943003D1 (xx)
IL (1) IL142292A0 (xx)
NO (1) NO20011817D0 (xx)
SE (1) SE9803482D0 (xx)
WO (1) WO2000021571A1 (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI20010764A0 (fi) * 2001-04-11 2001-04-11 Map Medical Technologies Oy Kationiset dekstraanijohdannaiset käytettäväksi munuaisten suojaamiseen
US8377484B1 (en) 2004-05-06 2013-02-19 Maria V. Tsiper Tumor encapsulation for prevention and treatment of metastatic cancer disease
EP2007816A1 (fr) * 2006-04-07 2008-12-31 Adocia Polysaccharides bifonctionnalises
FI119513B (fi) * 2007-03-07 2008-12-15 Dextech Medical Ab Muokatut hydroksipolymeerikonjugaatit, joilla on tappava vaikutus tuumorisoluihin
FR2919189A1 (fr) * 2007-07-26 2009-01-30 Cyclopharma Sa Lab Nouvelles compositions a base de polyosides greffes par des composes polyamines ou polysoufres.
US7998368B2 (en) * 2007-11-26 2011-08-16 United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Aqueous solution dispersement of carbon nanotubes
US20110118207A1 (en) * 2008-04-07 2011-05-19 Dextech Medical Ab Modified hydroxypolymer conjugates with bone seeking and tumor killing moieties
KR101450838B1 (ko) 2012-02-08 2014-10-15 가톨릭대학교 산학협력단 표적화 화학요법을 위한 암 인식 지능형 폴리펩티드 및 이의 제조방법
DE102014016901B4 (de) * 2014-09-17 2021-08-12 Friedrich-Schiller-Universität Jena Verfahren zur Herstellung für neue Dextranderivate als Wirkstoffträgersystem und deren Verwendung
FI127538B (en) 2016-06-22 2018-08-31 Dextech Medical Ab MODIFIED Dextran Conjugates
PL240772B1 (pl) * 2018-06-11 2022-06-06 Nanothea Spolka Akcyjna Sposób wytwarzania nanocząstek polimerowych chelatujących izotopy promieniotwórcze do zastosowania w diagnostyce i terapii

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5051257A (en) * 1989-05-09 1991-09-24 Pietronigro Dennis D Antineoplastic solution and method for treating neoplasms

Also Published As

Publication number Publication date
CA2347424A1 (en) 2000-04-20
AU759251B2 (en) 2003-04-10
NO20011817L (no) 2001-04-10
EP1137441A1 (en) 2001-10-04
WO2000021571A1 (en) 2000-04-20
SE9803482D0 (sv) 1998-10-13
AU1424700A (en) 2000-05-01
JP2002527407A (ja) 2002-08-27
US6569841B1 (en) 2003-05-27
DE69943003D1 (de) 2011-01-13
EP1137441B1 (en) 2010-12-01
ATE489971T1 (de) 2010-12-15
CA2347424C (en) 2009-12-08
NO20011817D0 (no) 2001-04-10

Similar Documents

Publication Publication Date Title
AU1378499A (en) Methods for treating prostate tumors using radioactive compositions
IL142292A0 (en) Ion exchange tumor targeting
GB2340121B (en) Delivery system
WO2004111192A3 (en) Targeted delivery to legumain-expressing cells
NZ500657A (en) Interleukin-3 gene therapy for cancer
HK1038929A1 (en) Cancer antigens based on tumor suppressor gene wt1product.
BR0306715A (pt) Métodos para diagnóstico e tratamento de tumores
PL335140A1 (en) Therapeutic agent for treating lymphatic system carcinomas
BR0010590A (pt) Emprego de filanto para estimulação objetivada do sistema imunológico
EP0900849A4 (en) GENE TRANSFER SYSTEM THROUGH RECEPTORS FOR TARGETED GENE THERAPY OF TUMORS
WO2000045853A3 (en) Treatment of tumors with genetically engineered herpes virus
EP1018548A4 (en) COMPOSITION BASED ON GLYCOSYLCERAMIDE ALPHA CAPABLE OF POTENTIALIZING CELLULAR IMMUNOGENICITY
NZ504938A (en) Tumor antigen peptide derivatives capable of binding to HLA-A24 antigen
WO2004110255A3 (en) Antineoplastic agents targeted via glut transporters
EP1122262A4 (en) SPECIFIC PEPTIDES FOR NEOVASCULARIZATION
CA2287838A1 (en) Radionuclide associated with nucleotide polyphosphate as tumor imaging agents
WO1999002704A3 (en) Dual specifically phosphatase and methods of use
AU3260093A (en) Use of creatine phosphate or phosphoenolpyruvic acid for the treatment of tumours
NZ240926A (en) Radioactively labelled modified oligonucleotide labelled with a therapeutic isotope and compositions thereof
WO2005007079A3 (en) Inactivators and bivalent inhibitors of glyoxalase i and methods of inhibiting tumor growth
ZA200106725B (en) Use of an enterobacterium protein ompa associated with an antigen for generating an antiviral antiparasitic or antitumoral cytotoxic response.
WO2000040752A3 (en) Cancer associated genes and their products
AU5992500A (en) Compound derived from an offset orf of the ice gene
TW200517125A (en) Pharmaceutical composition for treatment of solid cancers
AU2001220255A1 (en) Human cervical cancer suppressor protein, polynucleotide encoding the protein, cell transformed with the polynucleotide and method for suppressing proliferationof cancer cell using the expression vector